Young family walking and holding hands
the summit
NEWS

Why Is IVF Litigation Creating More Complex Medical Liability Exposures?

Recent court decisions involving fertility clinics demonstrate that a single IVF-related incident can give rise to multiple theories of liability, creating exposures that extend well beyond traditional medical malpractice.

A series of recent federal cases has examined allegations involving embryo storage, laboratory procedures, genetic testing, product defects, and embryo transfers. While each lawsuit involves different facts, together they illustrate how reproductive medicine is generating increasingly complex claims that may involve physicians, embryologists, laboratories, manufacturers, and fertility clinics simultaneously.

For retail agents, these developments reinforce an important underwriting reality: understanding what a fertility practice actually does can be just as important as identifying its medical specialty.

Why Are IVF Claims Becoming More Complex?

Many fertility claims now involve operational failures rather than allegations that a physician simply made an incorrect medical decision. Courts are increasingly being asked to evaluate issues such as embryo identification, chain-of-custody procedures, cryogenic storage, laboratory protocols, informed consent, and genetic testing.

In one recent case, a court allowed negligence claims involving the handling and transportation of frozen eggs to proceed after concluding there were factual questions surrounding storage and identification procedures. In another, claims involving allegedly defective embryo-culture media were allowed to move forward against a manufacturer, demonstrating how product liability can become intertwined with professional liability. These and other recent federal cases illustrate that a single incident may involve multiple defendants with very different responsibilities and insurance arrangements.

These cases illustrate that a single incident may involve multiple defendants with very different responsibilities and insurance arrangements.

Medical Malpractice May Be Only Part of the Exposure

Many fertility practices operate sophisticated laboratories alongside their clinical services. As a result, claims may extend beyond physician decision-making to include laboratory operations, specimen handling, equipment failures, vendor relationships, and documentation procedures.

That broader operational profile means insurers often need a much more detailed understanding of how a practice functions before evaluating coverage.

Our team is your team.

What Underwriters Want to Understand

Rather than focusing solely on physician credentials and claims history, underwriters evaluating fertility practices may also examine:

  • laboratory operations and accreditation;
  • embryo storage and monitoring procedures;
  • chain-of-custody and identification protocols; and
  • the use of outside laboratories, testing providers, or specialized vendors.

These operational details help carriers evaluate exposures that may not exist in a more traditional physician practice.

Why This Matters for Retail Agents

The recent litigation does not suggest that fertility practices have become uninsurable. Instead, it highlights why submissions for these risks often require greater detail than those for many other medical specialties.

Practices offering IVF services may present a combination of professional liability, laboratory operations, contractual relationships, and highly specialized clinical procedures. Providing a complete picture of those operations allows wholesale partners and underwriting markets to evaluate the risk more accurately and identify coverage solutions that reflect the practice's actual exposure.

An Evolving Area of Medical Liability

As reproductive medicine continues to advance, courts will likely continue addressing questions that extend beyond traditional medical malpractice. For retail agents, the recent cases serve as a reminder that emerging healthcare specialties often require a closer examination of both clinical and operational risk before coverage is placed.